Recent Advances and Future Prospects in Gene Delivery Platforms for Glioblastoma

溶瘤病毒 胶质母细胞瘤 医学 临床试验 基因传递 遗传增强 精密医学 胶质瘤 生物标志物 疾病 临床前试验 免疫疗法 单纯疱疹病毒 生物信息学 计算生物学 病毒载体 癌症 基因组编辑 癌症研究 临床疾病 输送系统 基因缺失 临床疗效
作者
Alexander F. Haddad,Rithvik Ramesh,Jorge Armando Pena Agudelo,C P Salha,Pranav Prakash,Shreya R. Aghi,James S. Trippett,Maria Graciela Castro,Manish K. Aghi
出处
期刊:JAMA Neurology [American Medical Association]
卷期号:83 (8): 808-808 被引量:2
标识
DOI:10.1001/jamaneurol.2026.2131
摘要

Importance: Glioblastoma (GBM) remains a disease with high mortality despite treatment with maximal safe surgical resection, radiation, and temozolomide. Standard of care for GBM has remained unchanged for decades. Gene therapies using both viral and nonviral platforms have the potential to significantly improve outcomes but have faced challenges related to delivery, intratumoral heterogeneity, and immunologic limitations. Observations: This review discusses the most recent progress in genetic therapies for gliomas, with a focus on clinical platforms and those nearing clinical translation. Oncolytic and nonlytic replicating viral therapies remain the most clinically advanced, with adeno-associated virus and nonviral systems approaching clinical translation. Treatment efficacy has been variable across trials, platforms, and payloads. Oncolytic herpes simplex virus (G47Δ, teserpaturev) has been conditionally approved for the treatment of gliomas in Japan, while next-generation constructs show a potential association between immunologic activation and survival. Common challenges include the verification and quantification of delivery efficiency, the balance between antivector and antitumor immunity, appropriately designed clinical trials, relevant modeling of vector behavior in the preclinical setting, regulatory clearance, and manufacturing. Conclusions and Relevance: Understanding the potential and limitations of gene therapies for gliomas is vital in navigating the path forward for these promising therapies. The future of these treatments will focus on improved clinical trial design with rapid confirmation and tracking of delivery, biomarker feedback and assay optimization, and combination strategies. A focus on delivery platform development can compress iteration cycles and lead to therapeutic benefit for patients with gliomas and other solid tumors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
完美世界的应助被Code_king采纳,获得10
刚刚
椰子云的应助被Code_king采纳,获得10
刚刚
浩瀚发布了新的文献求助20
刚刚
1秒前
1秒前
EVA发布了新的文献求助10
1秒前
余香的应助被zyyz616采纳,获得10
1秒前
1秒前
所所的应助被downloadpapers采纳,获得30
1秒前
高雅完成签到,获得积分20
1秒前
2秒前
2秒前
2秒前
学术搭子发布了新的文献求助10
2秒前
dong发布了新的文献求助10
2秒前
隐形伯云的应助被我不在迷茫采纳,获得10
3秒前
Nan完成签到,获得积分20
3秒前
3秒前
4秒前
4秒前
黑猫黑猫发布了新的文献求助10
4秒前
4秒前
oo发布了新的文献求助10
5秒前
CHOOOVY完成签到,获得积分10
5秒前
5秒前
白色热干面完成签到,获得积分10
5秒前
畅快夏菡完成签到,获得积分20
6秒前
6秒前
研友_VZG7GZ的应助被隐形的baby采纳,获得10
6秒前
6秒前
7秒前
黑粉头头发布了新的文献求助10
7秒前
7秒前
dong完成签到,获得积分20
8秒前
英吉利25发布了新的文献求助10
8秒前
赘婿的应助被帆蚌侠采纳,获得10
8秒前
9秒前
yiyi发布了新的文献求助10
9秒前
9秒前
123完成签到,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161749
求助须知:如何正确求助?哪些是违规求助? 9556240
关于积分的说明 21733360
捐赠科研通 7751657
什么是DOI,文献DOI怎么找? 3427566
关于科研通互助平台的介绍 2552632
邀请新用户注册赠送积分活动 2472047